-
1
-
-
33748357735
-
A2A adenosine receptor protects tumors from antitumor T cells
-
DOI 10.1073/pnas.0605251103
-
Ohta A, Gorelik E, Prasad SJ et al. A2A adenosine receptor protects tumors from antitumor T cells. Proc. Natl Acad. Sci. USA 103, 13132-13137 (2006). (Pubitemid 44338928)
-
(2006)
Proceedings of the National Academy of Sciences of the United States of America
, vol.103
, Issue.35
, pp. 13132-13137
-
-
Ohta, A.1
Gorelik, E.2
Prasad, S.J.3
Ronchese, F.4
Lukashev, D.5
Wong, M.K.K.6
Huang, X.7
Caldwell, S.8
Liu, K.9
Smith, P.10
Chen, J.-F.11
Jackson, E.K.12
Apasov, S.13
Abrams, S.14
Sitkovsky, M.15
-
2
-
-
0030785819
-
The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine
-
Blay J, White TD, Hoskin DW. The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine. Cancer Res. 57, 2602-2605 (1997). (Pubitemid 27283766)
-
(1997)
Cancer Research
, vol.57
, Issue.13
, pp. 2602-2605
-
-
Blay, J.1
White, T.D.2
Hoskin, D.W.3
-
3
-
-
0031933227
-
Ecto-enzyme and signaling functions of lymphocyte CD73
-
Resta R, Yamashita Y, Thompson LF. Ecto-enzyme and signaling functions of lymphocyte CD73. Immunol. Rev. 161, 95-109 (1998).
-
(1998)
Immunol. Rev.
, vol.161
, pp. 95-109
-
-
Resta, R.1
Yamashita, Y.2
Thompson, L.F.3
-
4
-
-
33947225356
-
Physiological roles for ecto-5′-nucleotidase (CD73)
-
Colgan SP, Eltzschig HK, Eckle T, Thompson LF. Physiological roles for ecto-5′-nucleotidase (CD73). Purinergic Signal. 2, 351-360 (2006).
-
(2006)
Purinergic Signal.
, vol.2
, pp. 351-360
-
-
Colgan, S.P.1
Eltzschig, H.K.2
Eckle, T.3
Thompson, L.F.4
-
5
-
-
77955750932
-
CD73: A novel target for cancer immunotherapy
-
Zhang B. CD73: a novel target for cancer immunotherapy. Cancer Res. 70, 6407-6411 (2010).
-
(2010)
Cancer Res.
, vol.70
, pp. 6407-6411
-
-
Zhang, B.1
-
6
-
-
79955960780
-
Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity
-
Deaglio S, Robson SC. Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity. Adv. Pharmacol. 61, 301-332 (2011).
-
(2011)
Adv. Pharmacol.
, vol.61
, pp. 301-332
-
-
Deaglio, S.1
Robson, S.C.2
-
7
-
-
84860388676
-
CD73: A potent suppressor of antitumor immune responses
-
Beavis PA, Stagg J, Darcy PK, Smyth MJ. CD73: a potent suppressor of antitumor immune responses. Trends Immunol. 33, 231-237 (2012).
-
(2012)
Trends Immunol.
, vol.33
, pp. 231-237
-
-
Beavis, P.A.1
Stagg, J.2
Darcy, P.K.3
Smyth, M.J.4
-
8
-
-
40249106427
-
Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review)
-
Hoskin DW, Mader JS, Furlong SJ, Conrad DM, Blay J. Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (review). Int. J. Oncol. 32, 527-535 (2008). (Pubitemid 351330458)
-
(2008)
International Journal of Oncology
, vol.32
, Issue.3
, pp. 527-535
-
-
Hoskin, D.W.1
Mader, J.S.2
Furlong, S.J.3
Conrad, D.M.4
Blay, J.5
-
9
-
-
77957564570
-
Extracellular adenosine triphosphate and adenosine in cancer
-
Stagg J, Smyth MJ. Extracellular adenosine triphosphate and adenosine in cancer. Oncogene 29, 5346-5358 (2010).
-
(2010)
Oncogene.
, vol.29
, pp. 5346-5358
-
-
Stagg, J.1
Smyth, M.J.2
-
10
-
-
0033796779
-
Tumor-promoting functions of adenosine
-
Spychala J. Tumor-promoting functions of adenosine. Pharmacol. Ther. 87, 161-173 (2000).
-
(2000)
Pharmacol. Ther.
, vol.87
, pp. 161-173
-
-
Spychala, J.1
-
11
-
-
77950231071
-
CD73 on tumor cells impairs antitumor T-cell responses: A novel mechanism of tumor-induced immune suppression
-
Jin D, Fan J, Wang L et al. CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression. Cancer Res. 70, 2245-2255 (2010).
-
(2010)
Cancer Res.
, vol.70
, pp. 2245-2255
-
-
Jin, D.1
Fan, J.2
Wang, L.3
-
12
-
-
75949112218
-
Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis
-
Stagg J, Divisekera U, McLaughlin N et al. Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis. Proc. Natl Acad. Sci. USA 107, 1547-1552 (2010).
-
(2010)
Proc. Natl Acad. Sci. USA.
, vol.107
, pp. 1547-1552
-
-
Stagg, J.1
Divisekera, U.2
McLaughlin, N.3
-
13
-
-
80054109170
-
Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity
-
Hausler SF, Montalban Del Barrio I, Strohschein J et al. Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity. Cancer Immunol. Immunother. 60(10), 1405-1418 (2011).
-
(2011)
Cancer Immunol. Immunother.
, vol.60
, Issue.10
, pp. 1405-1418
-
-
Hausler, S.F.1
Montalban Del Barrio, I.2
Strohschein, J.3
-
14
-
-
79960516623
-
Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production
-
Clayton A, Al-Taei S, Webber J, Mason MD, Tabi Z. Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production. J. Immunol. 187, 676-683 (2011).
-
(2011)
J. Immunol.
, vol.187
, pp. 676-683
-
-
Clayton, A.1
Al-Taei, S.2
Webber, J.3
Mason, M.D.4
Tabi, Z.5
-
15
-
-
79954576658
-
CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis
-
Stagg J, Divisekera U, Duret H et al. CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis. Cancer Res. 71, 2892-2900 (2011).
-
(2011)
Cancer Res.
, vol.71
, pp. 2892-2900
-
-
Stagg, J.1
Divisekera, U.2
Duret, H.3
-
16
-
-
79955153842
-
Altered purinergic signaling in CD73-deficient mice inhibits tumor progression
-
Yegutkin GG, Marttila-Ichihara F, Karikoski M et al. Altered purinergic signaling in CD73-deficient mice inhibits tumor progression. Eur. J. Immunol. 41, 1231-1241 (2011).
-
(2011)
Eur. J. Immunol.
, vol.41
, pp. 1231-1241
-
-
Yegutkin, G.G.1
Marttila-Ichihara, F.2
Karikoski, M.3
-
17
-
-
79957921286
-
CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice
-
Wang L, Fan J, Thompson LF et al. CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice. J. Clin. Invest. 121, 2371-2382 (2011).
-
(2011)
J. Clin. Invest.
, vol.121
, pp. 2371-2382
-
-
Wang, L.1
Fan, J.2
Thompson, L.F.3
-
18
-
-
34250351459
-
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
-
DOI 10.1084/jem.20062512
-
Deaglio S, Dwyer KM, Gao W et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204, 1257-1265 (2007). (Pubitemid 46919862)
-
(2007)
Journal of Experimental Medicine
, vol.204
, Issue.6
, pp. 1257-1265
-
-
Deaglio, S.1
Dwyer, K.M.2
Gao, W.3
Friedman, D.4
Usheva, A.5
Erat, A.6
Chen, J.-F.7
Enjyoji, K.8
Linden, J.9
Oukka, M.10
Kuchroo, V.K.11
Strom, T.B.12
Robson, S.C.13
-
19
-
-
84860382842
-
CD73-deficient mice are resistant to carcinogenesis
-
Stagg J, Beavis PA, Divisekera U et al. CD73-deficient mice are resistant to carcinogenesis. Cancer Res. 72, 2190-2196 (2012).
-
(2012)
Cancer Res.
, vol.72
, pp. 2190-2196
-
-
Stagg, J.1
Beavis, P.A.2
Divisekera, U.3
-
20
-
-
69849107597
-
Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments
-
Kryczek I, Banerjee M, Cheng P et al. Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood 114, 1141-1149 (2009).
-
(2009)
Blood
, vol.114
, pp. 1141-1149
-
-
Kryczek, I.1
Banerjee, M.2
Cheng, P.3
-
21
-
-
84858795377
-
Stat3 and Gfi-1 transcription factors control Th17 cell immunosuppressive activity via the regulation of ectonucleotidase expression
-
Chalmin F, Mignot G, Bruchard M et al. Stat3 and Gfi-1 transcription factors control Th17 cell immunosuppressive activity via the regulation of ectonucleotidase expression. Immunity 36, 362-373 (2012).
-
(2012)
Immunity.
, vol.36
, pp. 362-373
-
-
Chalmin, F.1
Mignot, G.2
Bruchard, M.3
-
22
-
-
82755162136
-
Adenosinergic regulation of the expansion and immunosuppressive activity of CD11b+Gr1+ cells
-
Ryzhov S, Novitskiy SV, Goldstein AE et al. Adenosinergic regulation of the expansion and immunosuppressive activity of CD11b+Gr1+ cells. J. Immunol. 187, 6120-6129 (2011).
-
(2011)
J. Immunol.
, vol.187
, pp. 6120-6129
-
-
Ryzhov, S.1
Novitskiy, S.V.2
Goldstein, A.E.3
-
23
-
-
84930472274
-
Inhibition of T-cell proliferation by murine multipotent mesenchymal stromal cells is mediated by CD39 expression and adenosine generation
-
Sattler C, Steinsdoerfer M, Offers M et al. Inhibition of T-cell proliferation by murine multipotent mesenchymal stromal cells is mediated by CD39 expression and adenosine generation. Cell Transplant. 20, 1221-1230 (2011).
-
(2011)
Cell Transplant.
, vol.20
, pp. 1221-1230
-
-
Sattler, C.1
Steinsdoerfer, M.2
Offers, M.3
-
24
-
-
79956361542
-
Mesenchymal stromal cells up-regulate CD39 and increase adenosine production to suppress activated T-lymphocytes
-
Saldanha-Araujo F, Ferreira FI, Palma PV et al. Mesenchymal stromal cells up-regulate CD39 and increase adenosine production to suppress activated T-lymphocytes. Stem Cell Res. 7, 66-74 (2011).
-
(2011)
Stem Cell Res.
, vol.7
, pp. 66-74
-
-
Saldanha-Araujo, F.1
Ferreira, F.I.2
Palma, P.V.3
-
25
-
-
0025055084
-
Production and characterization of monoclonal antibodies to the glycosyl phosphatidylinositol-anchored lymphocyte differentiation antigen ecto-5'-nucleotidase (CD73)
-
Thomson LF, Ruedi JM, Glass A et al. Production and characterization of monoclonal antibodies to the glycosyl phosphatidylinositol-anchored lymphocyte differentiation antigen ecto-5′-nucleotidase (CD73). Tissue Antigens 35, 9-19 (1990). (Pubitemid 20044689)
-
(1990)
Tissue Antigens
, vol.35
, Issue.1
, pp. 9-19
-
-
Thomson, L.F.1
Ruedi, J.M.2
Glass, A.3
Moldenhauer, G.4
Moller, P.5
Low, M.G.6
Klemens, M.R.7
Massaia, M.8
Lucas, A.H.9
-
26
-
-
0031684384
-
CD73 expression and fyn-dependent signaling on murine lymphocytes
-
DOI 10.1002/(SICI)1521-4141(199810)28:10<2981::AID-IMMU2981>3.0. CO;2-D
-
Yamashita Y, Hooker SW, Jiang H et al. CD73 expression and fyn-dependent signaling on murine lymphocytes. Eur. J. Immunol. 28, 2981-2990 (1998). (Pubitemid 28470244)
-
(1998)
European Journal of Immunology
, vol.28
, Issue.10
, pp. 2981-2990
-
-
Yamashita, Y.1
Hooker, S.W.2
Jiang, H.3
Laurent, A.B.4
Resta, R.5
Khare, K.6
Coe, A.7
Kincade, P.W.8
Thompson, L.F.9
-
27
-
-
0029817963
-
CD73 mediates adhesion of B cells to follicular dendritic cells
-
Airas L, Jalkanen S. CD73 mediates adhesion of B cells to follicular dendritic cells. Blood 88, 1755-1764 (1996). (Pubitemid 26307072)
-
(1996)
Blood
, vol.88
, Issue.5
, pp. 1755-1764
-
-
Airas, L.1
Jalkanen, S.2
-
28
-
-
33750472374
-
Ecto-5′-nucleotidase (eN, CD73) is coexpressed with metastasis promoting antigens in human melanoma cells
-
DOI 10.1080/15257770600894188, PII UH7184R5228M1178
-
Sadej R, Spychala J, Skladanowski AC. Ecto-5′-nucleotidase (eN, CD73) is coexpressed with metastasis promoting antigens in human melanoma cells. Nucleosides Nucleotides Nucleic Acids 25, 1119-1123 (2006). (Pubitemid 44651858)
-
(2006)
Nucleosides, Nucleotides and Nucleic Acids
, vol.25
, Issue.9-11
, pp. 1119-1123
-
-
Sadej, R.1
Spychala, J.2
Skladanowski, A.C.3
-
29
-
-
39149111587
-
Tenascin C interacts with ecto-5′-nucleotidase (eN) and regulates adenosine generation in cancer cells
-
Sadej R, Inai K, Rajfur Z et al. Tenascin C interacts with ecto-5′-nucleotidase (eN) and regulates adenosine generation in cancer cells. Biochim. Biophys. Acta 1782, 35-40 (2008).
-
(2008)
Biochim. Biophys. Acta.
, vol.1782
, pp. 35-40
-
-
Sadej, R.1
Inai, K.2
Rajfur, Z.3
-
30
-
-
38649133357
-
Ecto-5′-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells
-
DOI 10.1007/s00432-007-0292-z
-
Wang L, Zhou X, Zhou T et al. Ecto-5′-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells. J. Cancer Res. Clin. Oncol. 134, 365-372 (2008). (Pubitemid 351170058)
-
(2008)
Journal of Cancer Research and Clinical Oncology
, vol.134
, Issue.3
, pp. 365-372
-
-
Wang, L.1
Zhou, X.2
Zhou, T.3
Ma, D.4
Chen, S.5
Zhi, X.6
Yin, L.7
Shao, Z.8
Ou, Z.9
Zhou, P.10
-
31
-
-
47949117265
-
CD73 participates in cellular multiresistance program and protects against TRAIL-induced apoptosis
-
Mikhailov A, Sokolovskaya A, Yegutkin GG et al. CD73 participates in cellular multiresistance program and protects against TRAIL-induced apoptosis. J. Immunol. 181, 464-475 (2008).
-
(2008)
J. Immunol.
, vol.181
, pp. 464-475
-
-
Mikhailov, A.1
Sokolovskaya, A.2
Yegutkin, G.G.3
-
32
-
-
0034669958
-
CD73 engagement promotes lymphocyte binding to endothelial cells via a lymphocyte function-associated antigen-1-dependent mechanism
-
Airas L, Niemela J, Jalkanen S. CD73 engagement promotes lymphocyte binding to endothelial cells via a lymphocyte function-associated antigen-1-dependent mechanism. J. Immunol. 165, 5411-5417 (2000).
-
(2000)
J. Immunol.
, vol.165
, pp. 5411-5417
-
-
Airas, L.1
Niemela, J.2
Jalkanen, S.3
-
33
-
-
0031047221
-
Differential regulation and function of CD73, a glycosyl- phosphatidylinositol-linked 70-kD adhesion molecule, on lymphocytes and endothelial cells
-
DOI 10.1083/jcb.136.2.421
-
Airas L, Niemela J, Salmi M, Puurunen T, Smith DJ, Jalkanen S. Differential regulation and function of CD73, a glycosyl-phosphatidylinositol- linked 70 kD adhesion molecule, on lymphocytes and endothelial cells. J. Cell Biol. 136, 421-431 (1997). (Pubitemid 27063091)
-
(1997)
Journal of Cell Biology
, vol.136
, Issue.2
, pp. 421-431
-
-
Airas, L.1
Niemela, J.2
Salmi, M.3
Puurunen, T.4
Smith, D.J.5
Jalkanen, S.6
-
34
-
-
0027501009
-
+ T lymphocytes
-
Dianzani U, Redoglia V, Bragardo M et al. Co-stimulatory signal delivered by CD73 molecule to human CD45RAhiCD45ROlo (naive) CD8+ T lymphocytes. J. Immunol. 151, 3961-3970 (1993). (Pubitemid 23298729)
-
(1993)
Journal of Immunology
, vol.151
, Issue.8
, pp. 3961-3970
-
-
Dianzani, U.1
Redoglia, V.2
Bragardo, M.3
Attisano, C.4
Bianchi, A.5
Di Franco, D.6
Ramenghi, U.7
Wolff, H.8
Thompson, L.F.9
Pileri, A.10
Massaia, M.11
-
35
-
-
84856759921
-
Disarming suppressor cells to improve immunotherapy
-
Whiteside TL. Disarming suppressor cells to improve immunotherapy. Cancer Immunol. Immunother. 61, 283-288 (2012).
-
(2012)
Cancer Immunol. Immunother.
, vol.61
, pp. 283-288
-
-
Whiteside, T.L.1
-
36
-
-
33744534978
-
Cancer Immunotherapy and Preclinical Studies: Why We Are Not Wasting Our Time with Animal Experiments
-
DOI 10.1016/j.hoc.2006.03.001, PII S0889858806000499
-
Schreiber K, Rowley DA, Riethmuller G, Schreiber H. Cancer immunotherapy and preclinical studies: why we are not wasting our time with animal experiments. Hematol. Oncol. Clin. North Am. 20, 567-584 (2006). (Pubitemid 43817442)
-
(2006)
Hematology/Oncology Clinics of North America
, vol.20
, Issue.3
, pp. 567-584
-
-
Schreiber, K.1
Rowley, D.A.2
Riethmuller, G.3
Schreiber, H.4
-
37
-
-
0015118045
-
Cancer chemotherapy is many things: G.H.A. Clowes Memorial Lecture
-
Skipper HE. Cancer chemotherapy is many things: G.H.A. Clowes Memorial Lecture. Cancer Res. 31, 1173-1180 (1971).
-
(1971)
Cancer Res.
, vol.31
, pp. 1173-1180
-
-
Skipper, H.E.1
-
38
-
-
84860528921
-
A systematic analysis of experimental immunotherapies on tumors differing in size and duration of growth
-
Wen FT, Thisted RA, Rowley DA, Schreiber H. A systematic analysis of experimental immunotherapies on tumors differing in size and duration of growth. Oncoimmunology 1, 172-178 (2012).
-
(2012)
Oncoimmunology.
, vol.1
, pp. 172-178
-
-
Wen, F.T.1
Thisted, R.A.2
Rowley, D.A.3
Schreiber, H.4
-
39
-
-
76249128304
-
Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity
-
Aymeric L, Apetoh L, Ghiringhelli F et al. Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity. Cancer Res. 70, 855-858 (2010).
-
(2010)
Cancer Res.
, vol.70
, pp. 855-858
-
-
Aymeric, L.1
Apetoh, L.2
Ghiringhelli, F.3
-
40
-
-
68349141085
-
Heightened NTPDase-1/CD39 expression and angiogenesis in radiation proctitis
-
Sheth S, Bleibel W, Thukral C et al. Heightened NTPDase-1/CD39 expression and angiogenesis in radiation proctitis. Purinergic Signal. 5, 321-326 (2009).
-
(2009)
Purinergic Signal.
, vol.5
, pp. 321-326
-
-
Sheth, S.1
Bleibel, W.2
Thukral, C.3
-
41
-
-
77749246293
-
Involvement of purinergic signaling in cellular response to gamma radiation
-
Tsukimoto M, Homma T, Ohshima Y, Kojima S. Involvement of purinergic signaling in cellular response to gamma radiation. Radiat. Res. 173, 298-309 (2010).
-
(2010)
Radiat. Res.
, vol.173
, pp. 298-309
-
-
Tsukimoto, M.1
Homma, T.2
Ohshima, Y.3
Kojima, S.4
-
42
-
-
82955217840
-
CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death
-
Serra S, Horenstein AL, Vaisitti T et al. CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death. Blood 118, 6141-6152 (2011).
-
(2011)
Blood
, vol.118
, pp. 6141-6152
-
-
Serra, S.1
Horenstein, A.L.2
Vaisitti, T.3
-
43
-
-
80051789855
-
CD73 (5′-nucleotidase) expression has no prognostic value in children with acute lymphoblastic leukemia
-
Wieten E, van der Linden-Schrever BE, Sonneveld E, Veerman AJ, Pieters R. CD73 (5′-nucleotidase) expression has no prognostic value in children with acute lymphoblastic leukemia. Leukemia 25, 1374-1376 (2011).
-
(2011)
Leukemia.
, vol.25
, pp. 1374-1376
-
-
Wieten, E.1
Van Der Linden-Schrever, B.E.2
Sonneveld, E.3
Veerman, A.J.4
Pieters, R.5
-
44
-
-
84863722239
-
High expression of CD73 as a poor prognostic biomarker in human colorectal cancer
-
Wu XR, He XS, Chen YF et al. High expression of CD73 as a poor prognostic biomarker in human colorectal cancer. J. Surg. Oncol. 106(2), 130-137 (2012).
-
(2012)
J. Surg. Oncol.
, vol.106
, Issue.2
, pp. 130-137
-
-
Wu, X.R.1
He, X.S.2
Chen, Y.F.3
-
46
-
-
10644240767
-
Crucial role for ecto-5′-nucleotidase (CD73) in vascular leakage during hypoxia
-
DOI 10.1084/jem.20040915
-
Thompson LF, Eltzschig HK, Ibla JC et al. Crucial role for ecto-5′-nucleotidase (CD73) in vascular leakage during hypoxia. J. Exp. Med. 200, 1395-1405 (2004). (Pubitemid 39657287)
-
(2004)
Journal of Experimental Medicine
, vol.200
, Issue.11
, pp. 1395-1405
-
-
Thompson, L.F.1
Eltzschig, H.K.2
Ibla, J.C.3
Van De Wiele, C.J.4
Resta, R.5
Morote-Garcia, J.C.6
Colgan, S.P.7
-
47
-
-
1642444080
-
IFN-α Induced Adenosine Production on the Endothelium: A Mechanism Mediated by CD73 (Ecto-5′-Nucleotidase) Up-Regulation
-
Niemela J, Henttinen T, Yegutkin GG et al. IFN-alpha induced adenosine production on the endothelium: a mechanism mediated by CD73 (ecto-5′- nucleotidase) up-regulation. J. Immunol. 172, 1646-1653 (2004). (Pubitemid 38116812)
-
(2004)
Journal of Immunology
, vol.172
, Issue.3
, pp. 1646-1653
-
-
Niemela, J.1
Henttinen, T.2
Yegutkin, G.G.3
Airas, L.4
Kujari, A.-M.5
Rajala, P.6
Jalkanen, S.7
-
48
-
-
79957553355
-
Homing-associated molecules CD73 and VAP-1 as targets to prevent harmful inflammations and cancer spread
-
Salmi M, Jalkanen S. Homing-associated molecules CD73 and VAP-1 as targets to prevent harmful inflammations and cancer spread. FEBS Lett. 585, 1543-1550 (2011).
-
(2011)
FEBS Lett.
, vol.585
, pp. 1543-1550
-
-
Salmi, M.1
Jalkanen, S.2
-
50
-
-
84860538096
-
Deficiency of CD73/ecto-5′-nucleotidase in mice enhances acute graft-versus-host disease
-
Tsukamoto H, Chernogorova P, Ayata K et al. Deficiency of CD73/ecto-5′-nucleotidase in mice enhances acute graft-versus-host disease. Blood 119, 4554-4564 (2012).
-
(2012)
Blood
, vol.119
, pp. 4554-4564
-
-
Tsukamoto, H.1
Chernogorova, P.2
Ayata, K.3
-
51
-
-
79961011452
-
Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer
-
Kunzli BM, Bernlochner MI, Rath S et al. Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer. Purinergic Signal. 7, 231-241 (2011).
-
(2011)
Purinergic Signal.
, vol.7
, pp. 231-241
-
-
Kunzli, B.M.1
Bernlochner, M.I.2
Rath, S.3
-
52
-
-
77956134431
-
CD39/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice
-
Sun X, Wu Y, Gao W et al. CD39/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice. Gastroenterology 139, 1030-1040 (2010).
-
(2010)
Gastroenterology.
, vol.139
, pp. 1030-1040
-
-
Sun, X.1
Wu, Y.2
Gao, W.3
-
53
-
-
50949115838
-
Host A(2B) adenosine receptors promote carcinoma growth
-
Ryzhov S, Novitskiy SV, Zaynagetdinov R et al. Host A(2B) adenosine receptors promote carcinoma growth. Neoplasia 10, 987-995 (2008).
-
(2008)
Neoplasia.
, vol.10
, pp. 987-995
-
-
Ryzhov, S.1
Novitskiy, S.V.2
Zaynagetdinov, R.3
-
54
-
-
84855408091
-
Adenosine A2B receptor blockade slows growth of bladder and breast tumors
-
Cekic C, Sag D, Li Y, Theodorescu D, Strieter RM, Linden J. Adenosine A2B receptor blockade slows growth of bladder and breast tumors. J. Immunol. 188, 198-205 (2012).
-
(2012)
J. Immunol.
, vol.188
, pp. 198-205
-
-
Cekic, C.1
Sag, D.2
Li, Y.3
Theodorescu, D.4
Strieter, R.M.5
Linden, J.6
|